Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults
Open accessThe DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Diabetes is a major predictor of death from heart disease and stroke; its impact on nonvascular mortality, including specific cancers, is less understood. We examined the association of diabetes with cause-specific mortality, including deaths from specific cancers. RESEARCH DESIGN AND METHODS: A prospective cohort of 1,053,831 U.S. adults, without cancer at baseline, enrolled in the Cancer Prevention Study-II in 1982 and was followed for mortality until December 2008. At baseline, participants completed a self-administered questionnaire that included information on diabetes, smoking, physical activity, height, and weight. Multivariable-adjusted relative risks (RRs) (95% CI) were estimated using Cox proportional hazards regression. RESULTS: During 26 years of follow-up, 243,051 men and 222,109 women died. In multivariable models that controlled for age, BMI, and other variables, diabetes was associated with higher risk of all-cause mortality (women RR 1.90 [95% CI 1.87–1.93]; men 1.73 [1.70–1.75]). Among women, diabetes was associated with higher risk of death from cancers of the liver (1.40 [1.05–1.86]), pancreas (1.31 [1.14–1.51]), endometrium (1.33 [1.08–1.65]), colon (1.18 [1.04–1.33]), and breast (1.16 [1.03–1.29]). Among men, diabetes was associated with risk of death from cancers of the breast (4.20 [2.20–8.04]), liver (2.26 [1.89–2.70]), oral cavity and pharynx (1.44 [1.07–1.94]), pancreas (1.40 [1.23–1.59]), bladder (1.22 [1.01–1.47]), colon (1.15 [1.03–1.29]), and (inversely) prostate (0.88 [0.79–0.97]). Diabetes was also associated with higher risks of death involving the circulatory system, respiratory system, digestive system, genitourinary system, and external causes/accidental deaths. CONCLUSIONS: Diabetes is associated with higher risk of death for many diseases, including several specific forms of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The main limitation of these studies is the wide variation in methodologies including differences in the type, formulation, concentration, and duration of exposure to probiotics.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1710]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Several RCTs and systematic reviews/meta-analyses have noted a positive effect of probiotics on glucose, A1C, lipids, and BP.1705–1714”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1710]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297 · cited 1×
“The global prevalence of adults with diabetes is projected to reach 366 million in 2030, more than double the estimated prevalence for 2000 (1).”
BackgroundJemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696 · cited 1×
“BMI, a major risk factor for endometrial cancer incidence (35) and mortality (36).”
BackgroundRenehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219 · cited 1×
“BMI, a major risk factor for endometrial cancer incidence (35) and mortality (36).”
BackgroundThe Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125 · cited 2×
“Men and women with diabetes also experience about twofold higher risks of death from macrovascular disease, including heart disease and stroke (2,3).”
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
The Emerging Risk Factors Collaboration (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1008862 · Cited by 2,726
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366 · cited 2×
“Consistent with other prospective studies (6,18) and the conclusion from an expert report (8), we did not observe an association between diabetes and lung cancer mortality.”
BackgroundResultSelf-citationAssociation Between Smoking and Risk of Bladder Cancer Among Men and Women
Freedman, N. D. (2011) · JAMA · doi:10.1001/jama.2011.1142 · Cited by 1,141 · cited 1×
“Cigarette smoking is the primary risk factor for bladder cancer (31) and a weak risk factor for diabetes (32); thus, inclusion of smoking data in this study is a strength.”
BackgroundDiabetes and Cancer: A Consensus Report
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20078 · Cited by 1,055
Self-citationFasting Serum Glucose Level and Cancer Risk in Korean Men and Women
Jee, S. H. (2005) · JAMA · doi:10.1001/jama.293.2.194 · Cited by 988 · cited 1×
“Only one of these other studies stratified associations by sex; there was a higher risk of bladder cancer mortality among men, but results among women were not presented (5).”
Research works printed but not linked: 2
- Centers for Disease Control and Prevention, 2011, National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011
- World Health Organization, 1985, International Classification for Diseases
Cited by
Items 101–200 of 351
Cohort Profile: The Maule Cohort (MAUCO)
Catterina Ferreccio, R., Huidobro, A., Cortés, S., Claudia Bambs, S., Toro, P., Wyngard, V. V. D., Acevedo, J., Paredes, F., Venegas, P., Verdejo, H., et al. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa003 · Cited by 35
Unnatural Deaths in a National Cohort of People Diagnosed With Diabetes
Webb, R. T., Lichtenstein, P., Dahlin, M., Kapur, N., Ludvigsson, J. F., & Runeson, B. (2014) · Diabetes Care · doi:10.2337/dc14-0005 · Cited by 34
“Some studies have reported moderate elevations in risk for any type of unnatural death (11), suicide (12–15), and accidental death (12,13).”
BackgroundDiabetes and Cancer: A Twisted Bond
Stan, M. C., & Paul, D. (2024) · Oncology Reviews · doi:10.3389/or.2024.1354549 · Cited by 35
“It is noteworthy that several American and European studies have shown that individuals with type 2 diabetes have a lower risk of developing prostate cancer [68, 69].”
BackgroundGallagher, S., Kapur, A., Lovell, M. J., Jones, D. A., Kirkwood, A. A., Hassan, S., Archbold, A., Wragg, A., Uppal, R., & Yaqoob, M. M. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezt630 · Cited by 32
Bishnu, A., Sakpal, A., Ghosh, N., Choudhury, P., Chaudhury, K., & Ray, P. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.12.016 · Cited by 32
Masoudkabir, F., Mohammadifard, N., Mani, A., Ignaszewski, A. P., Davis, M. K., Vaseghi, G., Mansourian, M., Franco, C., Gotay, C. C., & Sarrafzadegan, N. (2023) · The Scientific World JOURNAL · doi:10.1155/2023/2404806 · Cited by 39
Forbes, A., Murrells, T., & Sinclair, A. J. (2016) · Diabetic Medicine · doi:10.1111/dme.13132 · Cited by 36
Nicholas, D., Andrieu, G. P., Strissel, K. J., Nikolajczyk, B. S., & Denis, G. V. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2320-0 · Cited by 35
“Because T2D associates with worse breast cancer outcomes [77], we suspect that diabetogenic inflammation is a critical factor that contributes to these outcomes.”
the Australasian Peers for Progress Diabetes Project Investigators, Riddell, M. A., Dunbar, J., Absetz, P., Wolfe, R. S., Li, H., Brand, M., Aziz, Z., & Oldenburg, B. F. (2016) · BMC Public Health · doi:10.1186/s12889-016-3538-3 · Cited by 36
Griffiths, R. I., Danese, M. D., Gleeson, M. L., & Valderas, J. M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-613 · Cited by 31
“Background Epidemiologic evidence suggests pre-existing diabetes is associated with increased risk of breast cancer [1], advanced cancer stage at diagnosis [2-5], altered treatment regimens [2,6-8], chemotherapy toxicity [6], breast cancer mortality in the general population [1,9,10], and overall mortality in those di…”
BackgroundHyperinsulinemia in Obesity, Inflammation, and Cancer
Zhang, A. M. Y., Wellberg, E. A., Kopp, J. L., & Johnson, J. D. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0131 · Cited by 35
Felix, A. S., McMeekin, D. S., Mutch, D. G., Walker, J. L., Creasman, W. T., Cohn, D. E., Ali, S., Moore, R. G., Downs, L. S., Ioffe, O. B., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.08.022 · Cited by 31
“Diabetes, a factor related to increased endometrial carcinoma risk, has been associated with increased mortality in some studies (11, 14, 17, 23, 24).”
BackgroundAntihyperglycaemic therapies and cancer risk
Lutz, S. Z., Staiger, H., Fritsche, A., & Häring, H. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114549553 · Cited by 30
“Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line.”
BackgroundNefs, G., Pop, V. J. M., Denollet, J., & Pouwer, F. (2016) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.114.154781 · Cited by 31
Peng, X., Meng, X., Cheng, W., Xing, Z., Huang, J., Fang, Z., Hu, X., Liu, Q., Zhu, Z., & Zhou, S. (2018) · Cancer Management and Research · doi:10.2147/cmar.s181178 · Cited by 30
Inoue, K., Nianogo, R. A., Telesca, D., Goto, A., Khachadourian, V., Tsugawa, Y., Sugiyama, T., Mayeda, E. R., & Ritz, B. R. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa263 · Cited by 30
“A cohort study of one million US adults reported diabetes to be associated with a higher risk of mortality for several diseases such as CVD, cancer, respiratory dysfunction, digestive diseases, genitourinary disorders and even accidents.(42) Although mortality and incidence of cardiovascular events among people with d…”
BackgroundRoderburg, C., Loosen, S. H., Hoyer, L., Luedde, T., & Kostev, K. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03861-7 · Cited by 30
Hong, J., He, Y., Fu, R., Si, Y.-X., Xu, B., Xu, J., Li, X., & Mao, F. (2022) · Open Medicine · doi:10.1515/med-2022-0470 · Cited by 36
Zhang, D., Zhao, Y., Wang, T., Xi, Y., Li, N., & Huang, H. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2868 · Cited by 30
Chen, J., Wang, Z., & Fu, X. Y. (2020) · BMC Cancer · doi:10.1186/s12885-020-07139-y · Cited by 30
“And the results were independent of Table 2 Subgroup analysis of relative risk for gallbladder cancer mortality in DM patients Subgroup No. of references HR and 95% CI Pa I 2% Pb Country Western countries 4 1.09 (1.05–1.13) < 0.0001 0% 0.29 Eastern countries 2 1.10 (1.06–1.13) 0.001 0% Follow-up duration ≦10 4 1.03 (0…”
InfluentialSacre, J. W., Harding, J. L., Shaw, J. E., & Magliano, D. J. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa270 · Cited by 30
Yera-Alos, I. B., Alonso-Carbonell, L., Valenzuela‐Silva, C., Iglesias, Á. T., Moreira-Martínez, M., Marrero-Rodríguez, I., López‐Mola, E., & López-Saura, P. A. (2013) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-14-44 · Cited by 32
“This death profile agrees with the literature for DFU patients [36,37].”
Koh, K. K., Lim, S. K., Choi, H., Lee, Y., Han, S. H., Lee, K., Oh, P. C., Sakuma, I., Shin, E. K., & Quon, M. J. (2013) · Diabetes · doi:10.2337/db13-0566 · Cited by 30
“This is particularly problematic from a therapeutic standpoint, since the presence of diabetes and insulin resistance increases the risk for cardiovascular diseases including coronary heart disease (5) and cancer mortality (6).”
BackgroundClinical overview of diabetes mellitus as a risk factor for cardiovascular death
Abuelgasim, E., Shah, S., Abuelgasim, B., Soni, N., Thomas, A., Elgasim, M., & Harky, A. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2202038 · Cited by 32
“Diabetes is associated with multiple co-morbidities, including increased risk of cardiovascular disease (CVD), as well as nephropathy (up to a quarter of type-2 diabetic patients present with microalbuminuria [3]), neuropathy (peripheral neuropathy associated in up to half of patients with diabetes [4]), retinopathy (…”
BackgroundRaun, S. H., Ali, M. S., Han, X., Henríquez‐Olguín, C., Pham, T. C. P., Meneses‐Valdés, R., Knudsen, J. R., Willemsen, A. C. H., Larsen, S., Jensen, T. E., et al. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13238 · Cited by 29
Wang, Y., Wang, B., Yan, S., Shen, F., Cao, H., Fan, J., Zhang, R., & Gu, J. F. (2016) · Annals of Epidemiology · doi:10.1016/j.annepidem.2016.09.006 · Cited by 29
Epidemiology, Pathogenesis, and Diagnostic Strategy of Diabetic Liver Disease in Japan
Sumida, Y., Shima, T., Mitsumoto, Y., Katayama, T., Umemura, A., Yamaguchi, K., Itoh, Y., Yoneda, M., & Okanoue, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124337 · Cited by 30
“A few decades ago, it was established that there is a substantially increased risk of mortality from cirrhosis and HCC in patients with T2D [44,45].”
BackgroundCause‐specific mortality by race in low‐income Black and White people with Type 2 diabetes
Conway, B. N., May, M. E., Fischl, A. F. R., Frisbee, J. C., Han, X., & Blot, W. J. (2014) · Diabetic Medicine · doi:10.1111/dme.12563 · Cited by 29
Gouveia, S. S. V., Gouveia, G. P. D. M., Souza, L. M., da Costa, B. C., Iles, B., Pinho, V. A., Vasconcelos, S. S., Medeiros, J. V. R., da Silva, R. L., & Pinheiro, L. G. P. (2021) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2021.01.004 · Cited by 31
Lindemann, K. Y., Cvancarova, M., & Eskild, A. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.09.088 · Cited by 28
Gapstur, S. M., Patel, A. V., Diver, W. R., Hildebrand, J. S., Gaudet, M. M., Jacobs, E. J., & Campbell, P. T. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0867 · Cited by 29
Self-citationHuang, W., Aune, D., Ferrari, G., Zhang, L., Lan, Y., Nie, J., Chen, X., Xu, D., Wang, Y., & Rezende, L. F. M. (2021) · Clinical Epidemiology · doi:10.2147/clep.s308220 · Cited by 27
“Patients with diabetes are at increased risk of cardiovascular disease (CVD),(2) cancer(3,4) and all-cause mortality.(3) Diabetes and its complications seriously affect patient’s quality of life and life expectancy.”
BackgroundMao, Y., Hu, W., Xia, B., Liu, L., Han, X., & Liu, Q. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.940335 · Cited by 29
Associations Between Diabetes, Leanness, and the Risk of Death in the Japanese General Population
Yano, Y., Kario, K., Ishikawa, S., Ojima, T., Gotoh, T., Kayaba, K., Tsutsumi, A., Shimada, K., Nakamura, Y., Kajii, E., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1736 · Cited by 28
Kim, D., Li, A. A., Cholankeril, G. T., Kim, S. H., Ingelsson, E., Knowles, J. W., Harrington, R. A., & Ahmed, A. (2019) · Diabetologia · doi:10.1007/s00125-019-4870-9 · Cited by 27
Second-line Glucose-Lowering Therapy in Type 2 Diabetes Mellitus
Shin, J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1171-0 · Cited by 31
Fan, Z., Xu, J., Ge, M., Huang, J., Ni, H., Shen, W., & Chen, H. (2024) · Journal of Advanced Nursing · doi:10.1111/jan.16074 · Cited by 30
Funck, K. L., Laugesen, E., Høyem, P., Fleischer, J., Cichosz, S. L., Christiansen, J. S., Hansen, T. K., & Poulsen, P. L. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv197 · Cited by 26
Insulin resistance and adrenal incidentalomas: A bidirectional relationship
Sydney, G. I., Ioakim, K. J., & Paschou, S. Α. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.12.002 · Cited by 28
Zhou, L., Yang, S., Li, Y., Xue, C., & Wan, R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1448728 · Cited by 25
Zhang, T., Zhang, Z., Wang, X., Kuang, H., Xu, Q., Li, H., Xu, C., Zhao, K., Zhang, C., & Hao, M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15929 · Cited by 27
“3 – 10 However, it is currently believed that both obesity and fat distribution together are key factors in predicting co-morbidities and negative health outcomes.”
Dowling, R. J. O., Kalinsky, K. M., Hayes, D. F., Bidard, F., Cescon, D. W., Chandarlapaty, S., Deasy, J. O., Dowsett, M., Gray, R. J., Henry, N. L., et al. (2019) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkz050 · Cited by 25
KASE, N. G., Friedman, E. G., Brodman, M. L., Kang, C., Gallagher, E. J., & LeRoith, D. (2020) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2020.05.051 · Cited by 28
History of lower-limb complications and risk of cancer death in people with type 2 diabetes
Mohammedi, K., Harrap, S. B., Mancia, G., Marre, M., Poulter, N. R., Chalmers, J. P., & Woodward, M. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01198-y · Cited by 25
Huang, N. H., Tang, C., Li, S., Ma, W., Zhai, X., Liu, K., Sheerah, H. A., & Cao, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.976817 · Cited by 24
“Diabetes is one of the most critical risk factors for CVD (12) and elevates morbidity and mortality of CVD mainly attributsed to vascular inflammation and endothelial dysfunction (13).”
BackgroundSoltani, S., Abdollahi, S., Aune, D., & Jayedi, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-81671-0 · Cited by 22
Sharma, A., Brito, F. D. S., Sun, J., Thomas, L. E., Haffner, S. M., Holman, R. R., & Lópes, R. D. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.12.011 · Cited by 23
Beltran-Valls, M. R., Cabanas-Sánchez, V., Sadarangani, K. P., Rodríguez-Artalejo, F., Moliner-Urdiales, D., & Martínez-Gómez, D. (2023) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101410 · Cited by 21
All in the family: Clueing into the link between metabolic syndrome and hematologic malignancies
Karmali, R., Dalovisio, A. P., Borgia, J. A., Venugopal, P., Kim, B. W., Grant-Szymanski, K., Hari, P., & Lazarus, H. M. (2014) · Blood Reviews · doi:10.1016/j.blre.2014.09.010 · Cited by 21
Cancer causes dysfunctional insulin signaling and glucose transport in a muscle‐type‐specific manner
Raun, S. H., Knudsen, J. R., Han, X., Jensen, T. E., & Sylow, L. (2022) · The FASEB Journal · doi:10.1096/fj.202101759r · Cited by 24
Yera-Alos, I. B. (2013) · Advances in Pharmacoepidemiology & Drug Safety · doi:10.4172/2167-1052.1000128 · Cited by 21
Marrone, M. T., Selvin, E., Barber, J. R., Platz, E. A., & Joshu, C. E. (2018) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-18-0216 · Cited by 20
“In contrast, in the Cancer Prevention Study-II, selfreported diabetes (versus no) was associated with a lower risk of prostate cancer mortality (13).”
ResultWang, J., Wu, Y., Shin, S., Tien, K., Chin, M.-C., & Hwu, C. (2019) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2019.06.017 · Cited by 20
Ning, X., Ding, N., Ballew, S. H., Hicks, C. W., Coresh, J., Selvin, E., Pankow, J. S., Tang, W., & Matsushita, K. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.09.031 · Cited by 20
Exercise—A Panacea of Metabolic Dysregulation in Cancer: Physiological and Molecular Insights
Raun, S. H., Buch‐Larsen, K., Schwarz, P., & Sylow, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073469 · Cited by 22
“More recent studies also show that diabetes is associated with a 10–30% increased overall risk of cancer death, although the risk markedly varies by cancer site, sex, and treatments [22,25,26].”
BackgroundGrecian, S. M., McLachlan, S., Fallowfield, J. A., Kearns, P. K. A., Hayes, P. C., Guha, I. N., Morling, J. R., Glancy, S., Williamson, R. M., Reynolds, R. M., et al. (2020) · Liver International · doi:10.1111/liv.14590 · Cited by 19
Impact of Type 2 Diabetes Mellitus on Survival in Head and Neck Squamous Cell Carcinoma
Foreman, A., Lee, D. J., McMullen, C. P., de Almeida, J. R., Muhanna, N., Gama, R. R., Giuliani, M., Liu, G., Bratman, S. V., Huang, S. H., et al. (2017) · Otolaryngology · doi:10.1177/0194599817726756 · Cited by 20
“001 Surgery 502 (20) 431 (20) 71 (22) Surgery 1 RT 287 (12) 247 (11) 40 (13) Surgery 1 CRT 59 (2) 52 (2) 7 (2) Surgery 1 chemotherapy 38 (2) 38 (2) 0 (0) Primary RT 993 (40) 844 (39) 149 (47) Primary CRT 610 (25) 558 (26) 52 (16) Follow-up, y 4 (0, 9.”
An Analysis of The Morbidity and Mortality of Diabetes Mellitus in a Forensic Context
Zhou, C., & Byard, R. W. (2017) · Journal of Forensic Sciences · doi:10.1111/1556-4029.13674 · Cited by 19
Oh, J. J., Kang, M., Jo, J. K., Lee, H. M., Byun, S., Lee, S.-C., Lee, S.-C., & Hong, S. K. (2015) · International Journal of Urology · doi:10.1111/iju.12901 · Cited by 19
Stidsen, J. V., Nielsen, J. S., Henriksen, J. E., Friborg, S. G., Thomsen, R. W., Olesen, T. B., Olsen, M. H., & Beck‐Nielsen, H. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017493 · Cited by 19
Glycemic Status and Prognosis of Patients with Squamous Cell Carcinoma of the Esophagus
Okamura, A., Watanabe, M., Imamura, Y., Hayami, M., Yamashita, K., Kurogochi, T., & Mine, S. (2017) · World Journal of Surgery · doi:10.1007/s00268-017-4036-1 · Cited by 18
Reducing the Burden of Mortality in Older People With Diabetes: A Review of Current Research
Forbes, A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00133 · Cited by 20
Takenaga, K., Akimoto, M., Koshikawa, N., & Nagase, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-82617-2 · Cited by 17
The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism
Sankofi, B. M., Valencia-Rincón, E., Sekhri, M., Ponton-Almodovar, A. L., Bernard, J. J., & Wellberg, E. A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217875 · Cited by 18
OP449 inhibits breast cancer growth without adverse metabolic effects
Shlomai, G., Zelenko, Z., Antoniou, I. M., Stasinopoulos, M., Tobin‐Hess, A., Vitek, M. P., LeRoith, D., & Gallagher, E. J. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0077 · Cited by 20
The influence of diabetes severity on receipt of guideline-concordant treatment for breast cancer
Sabatino, S. A., Thompson, T., Wu, X., Fleming, S. T., Kimmick, G. G., Trentham‐Dietz, A., Cress, R. D., & Anderson, R. T. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2998-3 · Cited by 17
Pathogenesis of Nonalcoholic Fatty Liver Disease
Machado, M. V., & Diehl, A. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00025-2 · Cited by 21
Drosophilaas a Model System to Study Nonautonomous Mechanisms Affecting Tumour Growth and Cell Death
Parvy, J.-P., Hodgson, J. A., & Cordero, J. B. (2018) · BioMed Research International · doi:10.1155/2018/7152962 · Cited by 20
“Preexisting obesity and diabetes promoted tumour growth in a rat cancer model [94], while a study of over one million patients over 26 years identified diabetes as a predictor of both cancer development and cancer death [102].”
BackgroundDemarchis, L., Chiloiro, S., Giampietro, A., Marinis, L. D., Bianchi, A., Fleseriu, M., & Pontecorvi, A. (2025) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-025-09957-6 · Cited by 19
“Patients with diabetes mellitus appear to have a higher mortality rate than subjects without diabetes [67, 68].”
Chen, C., Tsai, M. K., Lee, J. H., Lin, R., Hsu, C. Y., Wen, C., Wu, X., Chu, T.-W. D., & Wen, C. P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.835901 · Cited by 18
“Because relatively few pancreatic cancer deaths were noted in the total cohort, age and variables at enrollment were adjusted for these models in Tables 3, 4 (44).”
BackgroundChina’s Burgeoning Epidemic of Diabetes-Associated Mortality
Chan, M. (2017) · JAMA · doi:10.1001/jama.2016.19736 · Cited by 20
Zhu, B. T. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022012 · Cited by 17
Flausino, L. E., Carrasco, A. G. M., Furuya, T. K., Tuan, W., & Chammas, R. J. (2025) · BMC Cancer · doi:10.1186/s12885-025-13966-8 · Cited by 16
“These factors not only accelerate cancer progression but also increase mortality rates in patients with colon, liver, intrahepatic bile duct, and pancreatic cancers [59].”
Furan-induced cardiotoxicity in diabetic rats and protective role of lycopene
Saracoğlu, G., Baş, H., & Pandır, D. (2018) · Journal of Food Biochemistry · doi:10.1111/jfbc.12738 · Cited by 15
Associations of the consumer food environment with eating behaviours and BMI
Zhao, A., McGowan, C., Zenk, S. N., & Kershaw, K. N. (2020) · Public Health Nutrition · doi:10.1017/s1368980020002633 · Cited by 16
Cong, M., Zhu, W., Wang, C., Fu, Z., Song, C., Dai, Z., Yao, K., Guo, Z., Lin, Y., Shi, Y., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3397 · Cited by 15
Risk of colon cancer recurrence in relation to diabetes
Chubak, J., Yu, O., Ziebell, R. A., Bowles, E. J. A., Sterrett, A. T., Fujii, M., Boggs, J. M., Burnett‐Hartman, A. N., Boudreau, D. M., Chen, L., et al. (2018) · Cancer Causes & Control · doi:10.1007/s10552-018-1083-3 · Cited by 15
Maharani, A., Sujarwoto, S., Praveen, D., Oceandy, D., Tampubolon, G., & Patel, A. A. (2024) · PLOS Digital Health · doi:10.1371/journal.pdig.0000476 · Cited by 15
Self-citationDendrobium officinale Prevents Early Complications in Streptozotocin‐Induced Diabetic Rats
Hou, S., Liang, C., Liu, H., Zhu, D., Wu, Y., Liang, J., Zhao, Y., Guo, J., Huang, S. M., & Lai, X. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/6385850 · Cited by 14
Bergram, M., Nasr, P., Iredahl, F., Kechagias, S., Rådholm, K., & Ekstedt, M. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1984572 · Cited by 15
Campbell, P. T., Newton, C. C., Jacobs, E. J., McCullough, M. L., Wang, Y., Rees‐Punia, E., Guinter, M. A., Murphy, N., Koshiol, J. E., Dehal, A. N., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0082 · Cited by 15
Self-citationChen, M., Wu, C., Zhang, J., Zhang, H., Sun, Y.-D., Tian, S.-L., & Han, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.996228 · Cited by 14
“Patients with diabetes have a 126% higher risk of cancer-related death from liver cancer than those without diabetes (10).”
BackgroundShen, T., Zhao, J., Li, W., Wang, X., Gao, Y., Wang, Z., Hu, S., & Cai, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1280060 · Cited by 16
Ghost-time bias from imperfect mortality ascertainment in aging cohorts
Jacobs, E. J., Newton, C. C., Wang, Y., Campbell, P. T., Flanders, W. D., & Gapstur, S. M. (2018) · Annals of Epidemiology · doi:10.1016/j.annepidem.2018.06.002 · Cited by 13
Self-citationCheng, X., Jia, X., Wang, C., Zhou, S., Chen, J., Chen, L., & Chen, J. (2023) · World Journal of Surgical Oncology · doi:10.1186/s12957-023-02990-2 · Cited by 14
Modifiers of Liver-Related Manifestation in the Course of NAFLD
Nasr, P., Blomdahl, J., Kechagias, S., & Ekstedt, M. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200310142803 · Cited by 13
“[ 71] The relationship between T2DM and HCC is well established.”
BackgroundChen, B., Chen, C., Zhao, X., & Wu, X. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1383029 · Cited by 12
Colpani, V., Oppermann, K., & Spritzer, P. M. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-194 · Cited by 12
“The association between DM and CVD has been suggested to be stronger in women than in men [6,37,39].”
BackgroundHydes, T., Cuthbertson, D. J., Graef, S., Berhane, S., Teng, M. J., Skowrońska, A., Singh, P., Dhanaraj, S., Tahrani, A. A., & Johnson, P. J. (2022) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.12.011 · Cited by 12
Han, E., Song, S. O., Kim, H. S., Son, K. J., Jee, S. H., Soo, B., & Lee, B. (2020) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1440 · Cited by 12
“Diabetes is closely related to an increased risk for malignant neoplasms in the breast, liver, pancreas, endometrium, colon, rectum, and bladder [24], and deaths from breast and colorectal cancer have decreased in the United States population with diabetes [25].”
BackgroundResidential distance from major urban areas, diabetes and cardiovascular mortality in Australia
Magliano, D. J., Cohen, K., Harding, J. L., & Shaw, J. E. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.029 · Cited by 12
Ederaine, S. A., Dominguez, J. L., Harvey, J. A., Mangold, A. R., Cook, C. B., Kosiorek, H., Buras, M. R., Coppola, K., & Karlin, N. J. (2021) · Future Science OA · doi:10.2144/fsoa-2020-0150 · Cited by 12
Preexisting Type 2 Diabetes and Survival among Patients with Colorectal Cancer
Yuan, C., Zhang, X., Babić, A., Morales‐Oyarvide, V., Zhang, Y., Smith‐Warner, S. A., Wu, K., Wang, M., Wolpin, B. M., Meyerhardt, J. A., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1083 · Cited by 13
Lallukka, T. M., Ervasti, J. M., Mittendorfer‐Rutz, E., Tinghög, P., Kjeldgård, L., Pentti, J., Virtanen, M., & Alexanderson, K. A. E. (2016) · Scandinavian Journal of Public Health · doi:10.1177/1403494816655059 · Cited by 13
Wang, Y., Sun, Y., Tang, J., Zhou, W., Liu, X., Bi, Y., & Zhang, Z.-J. (2018) · Annals of Epidemiology · doi:10.1016/j.annepidem.2018.11.010 · Cited by 11
Kim, D., Alshuwaykh, O. S., Dennis, B. B., Cholankeril, G. T., Knowles, J. W., & Ahmed, A. (2022) · Digestive and Liver Disease · doi:10.1016/j.dld.2022.09.006 · Cited by 12
“[5] Campbell PT, Newton CC, Patel AV, et al.”
Yamauchi, T., Inagaki, M., Yonemoto, N., Iwasaki, M., Akechi, T., Sawada, N., Iso, H., Noda, M., & Tsugane, S. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.11.008 · Cited by 11
Ye, J., Qian, M.-H., Shi, L., & Lu, Y. (2019) · Diabetes Therapy · doi:10.1007/s13300-018-0557-3 · Cited by 11
Erkinantti, S., Hautakoski, A., Sund, R., Arffman, M., Urpilainen, E., Puistola, U., Jukkola‐Vuorinen, A., Karihtala, P., & Läärä, E. (2022) · Cancer Control · doi:10.1177/10732748221134090 · Cited by 10
Ciardullo, S., Morabito, G., Rea, F., Savaré, L., Perseghin, G., & Corrao, G. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae182 · Cited by 10
Metadata
- Authors
- Campbell, P. T., Newton, C. C., Patel, A. V., Jacobs, E. J., & Gapstur, S. M.
- Affiliations
- American Cancer Society (US)
- Corresponding author
- Campbell, Peter T.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-08-14
- Volume
- 35
- Issue
- 9
- Pages
- 1835-1844
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3425000
- OpenAlex
- W1974792145
- Cited by
- 339
- References
- 41
- Citations by year
- 2026: 8 · 2025: 17 · 2024: 26 · 2023: 16 · 2022: 27 · 2021: 31 · 2020: 33 · 2019: 13 · 2018: 35 · 2017: 27 · 2016: 26 · 2015: 25 · 2014: 22 · 2013: 23 · 2012: 8
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- diabetes mellitus, cause-specific mortality, cancer mortality, all-cause mortality, liver cancer, pancreatic cancer, breast cancer, colon cancer, endometrial cancer, bladder cancer, oral cavity and pharynx cancer, cardiovascular mortality, sex differences, Cancer Prevention Study II, prospective cohort, smoking, physical activity, body mass index
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Diabetes Mellitus, Humans, Middle Aged, Neoplasms, Prospective Studies, Surveys and Questionnaires, Risk Factors, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.